Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick C Fox

Showing results (281-290 of 436) with videos related to

Pageof 44
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Human Brain Mapping|March 26, 2018
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imagingThomas D Parker, Catherine F Slattery, Jiaying Zhang, et al.
The Lancet. Neurology|August 4, 2009
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline dataSarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, et al.
Brain : a Journal of Neurology|February 1, 2008
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK seriesJonathan Beck, Jonathan D Rohrer, Tracy Campbell, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2025
Modified titration of donanemab reduces ARIA risk and maintains amyloid reductionHong Wang, Emel Serap Monkul Nery, Paul Ardayfio, et al.
Neuroimage|March 24, 2015
Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's diseasePrashanthi Vemuri, Matthew L Senjem, Jeffrey L Gunter, et al.
Human Molecular Genetics|July 3, 2015
Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPTTeresa Sposito, Elisavet Preza, Colin J Mahoney, et al.
Alzheimer'S Research & Therapy|April 29, 2020
Imaging biomarkers in neurodegeneration: current and future practicesPeter N E Young, Mar Estarellas, Emma Coomans, et al.
Pageof 44

Showing results (281-290 of 436) with videos related to

Sort By:
Pageof 44
Journal of Neurology, Neurosurgery, and Psychiatry|April 15, 2019
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive questMartha S Foiani, Claudia Cicognola, Natalia Ermann, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Human Brain Mapping|March 26, 2018
Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imagingThomas D Parker, Catherine F Slattery, Jiaying Zhang, et al.
The Lancet. Neurology|August 4, 2009
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline dataSarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, et al.
Brain : a Journal of Neurology|February 1, 2008
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK seriesJonathan Beck, Jonathan D Rohrer, Tracy Campbell, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2025
Modified titration of donanemab reduces ARIA risk and maintains amyloid reductionHong Wang, Emel Serap Monkul Nery, Paul Ardayfio, et al.
Neuroimage|March 24, 2015
Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's diseasePrashanthi Vemuri, Matthew L Senjem, Jeffrey L Gunter, et al.
Human Molecular Genetics|July 3, 2015
Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPTTeresa Sposito, Elisavet Preza, Colin J Mahoney, et al.
Alzheimer'S Research & Therapy|April 29, 2020
Imaging biomarkers in neurodegeneration: current and future practicesPeter N E Young, Mar Estarellas, Emma Coomans, et al.
Pageof 44